Critical role of bare-metal stent controls in trials of drug-eluting stents [5] (multiple letters)

European Heart Journal

Volumn 26, Issue 16, 2005, Pages 1686-1687

  Biondi Zoccai, Giuseppe G L ^a   Agostoni, Pierfrancesco ^b   Abbate, Antonio ^c   Airoldi, Flavio ^a   Colombo, Antonio ^d   Kastrati, Adnan ^e   Pache, Jürgen ^e   Dibra, Alban ^e   Schömig, Albert ^e  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b MIDDELHEIM HOSPITAL   (Belgium)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d EMO GVM CENTRO CUORE COLUMBUS   (Italy)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

METAL; RAPAMYCIN;

ANALYTIC METHOD; CARDIOVASCULAR RISK; CLINICAL TRIAL; COMPARATIVE STUDY; DEVICE; DRUG EFFECT; DRUG ELUTING STENT; HUMAN; LETTER; META ANALYSIS; PRIORITY JOURNAL; RESTENOSIS; RISK REDUCTION;

CORONARY RESTENOSIS; DRUG IMPLANTS; HUMANS; RANDOMIZED CONTROLLED TRIALS; STENTS;

EID: 25844457638     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi365     Document Type: Letter

References (0)